about
Optimal Use of Vaccines for Control of Influenza A Virus in SwineAdvanced vaccine candidates for Lassa feverSindbis virus as a human pathogen-epidemiology, clinical picture and pathogenesis.Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus.Vaccine development for protecting swine against influenza virus.The search for animal models for Lassa fever vaccine developmentDevelopment and evaluation of a replicon particle vaccine expressing the E2 glycoprotein of bovine viral diarrhea virus (BVDV) in cattle.Vaccine Platforms to Control Arenaviral Hemorrhagic FeversNovel vaccine strategies against emerging viruses.De Novo Transcriptome Analysis Shows That SAV-3 Infection Upregulates Pattern Recognition Receptors of the Endosomal Toll-Like and RIG-I-Like Receptor Signaling Pathways in Macrophage/Dendritic Like TO-Cells.Immunity to bovine herpesvirus 1: II. Adaptive immunity and vaccinology.RNA-based viral vectors.The alien replicon: Artificial genetic constructs to direct the synthesis of transmissible self-replicating RNAs: In vivo synthesised heterologous (alien) RNA constructs are capable of initiating self-replication following transmission to the host oVaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinations.Infectious bursal disease virus as a replication-incompetent viral vector expressing green fluorescent protein.Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells.Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines.Semliki Forest VirusExpression SystemComparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A VirusesImmunization with a suicidal DNA vaccine expressing the E glycoprotein protects ducklings against duck Tembusu virus
P2860
Q26783503-7C23BF4B-01BD-45AB-A6EA-AB5FEE1491C7Q26823627-8A0221FF-6F26-4F0E-A1E4-4C6FD8EA03EAQ30251764-A49BB3E7-B1F9-402D-9083-58C10EB346D1Q30354025-16C070C8-13BE-4FC7-A136-0BF00BB74120Q30424943-00CAEAE9-D56A-442B-AAC7-C6B136C2402EQ36588064-453E54C6-7EB7-4B5E-B0EE-1B5D91BEA806Q36591679-0F7261A0-18E5-48AA-B0C6-D7BE5B99ABF0Q36612929-42C20928-6366-4724-87FE-2BA839E6E255Q36816140-AA638BCF-EC88-4451-A4B5-CEEDAA4F284FQ36846041-6A943D06-C76D-4127-AA91-E5071B63F1A4Q38116993-45D77B69-C4C5-405D-80F1-0ED0233FBC6FQ38266413-655CD593-1ED9-48B0-BE34-87C8072E5C0DQ38266429-DA778688-32D0-4808-8C87-0438A7EC4E81Q38269845-62FD6F0D-85EB-4BFA-9412-54ACF808B6BCQ38574574-CCC126C0-115A-4ACD-AB88-529E6EC3A75AQ38744228-B5E738C9-520E-48F4-8A48-56A1A4500D01Q40130716-CC02B6DF-C68B-4720-9D4B-2CE2D3B8CA8CQ42185476-F2B092F0-46C0-48E4-9D71-345EA4BE9676Q56922178-DC937F81-C0E5-4474-B386-AC371F1E78F6Q58706119-EE8C651D-C6A1-4F54-9CE1-AEF315C26020Q58741516-3F187E2E-DA1E-4A2F-9383-C62FB5B49E6F
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Alphavirus replicon vaccines.
@en
Alphavirus replicon vaccines.
@nl
type
label
Alphavirus replicon vaccines.
@en
Alphavirus replicon vaccines.
@nl
prefLabel
Alphavirus replicon vaccines.
@en
Alphavirus replicon vaccines.
@nl
P2093
P2860
P1476
Alphavirus replicon vaccines.
@en
P2093
D L Hank Harris
Kurt I Kamrud
Ryan L Vander Veen
P2860
P356
10.1017/S1466252312000011
P577
2012-03-21T00:00:00Z